TriaGen Wealth Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,812
Closed -$494K 162
2023
Q4
$494K Buy
3,812
+1,136
+42% +$157K 0.24% 92
2023
Q3
$436K Buy
+2,676
New +$471K 0.22% 98
2022
Q2
Sell
-6,279
Closed -$474K 154
2022
Q1
$474K Buy
+6,279
New +$429K 0.25% 101

Other funds holding ACLS

TriaGen Wealth Management's ACLS Position: Q1 2024 in Review

TriaGen Wealth Management sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 3,812 shares — an estimated $494K sold.

TriaGen Wealth Management first reported a position in ACLS in Q1 2022 and held it in 3 quarters. The position peaked at $494K in Q4 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • TriaGen Wealth Management reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • TriaGen Wealth Management sold 3,812 Axcelis shares in Q1 2024, an estimated $494K.
  • TriaGen Wealth Management first reported a position in Axcelis in Q1 2022 and held it in 3 quarters.
  • TriaGen Wealth Management's Axcelis position peaked at $494K in Q4 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on TriaGen Wealth Management's 13F filing for Q1 2024, filed 23 Apr 2024.